Semler Scientific, Inc. is a healthcare technology company focused on improving clinical efficiency and outcomes. Its flagship product, QuantaFlo®, is an FDA-cleared device used for early detection of peripheral arterial disease (PAD), a condition linked to cardiovascular risk. Designed for point-of-care use, QuantaFlo® supports physicians in diagnosing PAD quickly and accurately, facilitating timely intervention. Semler serves healthcare providers, insurance plans, and integrated delivery networks, offering solutions that streamline chronic disease management. By prioritizing innovation and early detection, Semler Scientific contributes to better patient care and cost-effective healthcare delivery.